Managers / Q4 2019 · view latest →
ZEVENBERGEN CAPITAL INVESTMENTS LLC
CIK 0001276918 · 326 ADMIRAL WAY, STE 200, EDMONDS, WA, 98020 · 2066828469
Summary
Zevenbergen Capital Investments LLC reported $2.7B in U.S.-listed holdings across 117 positions for Q4 2019.
Its largest position, TSLA, represents 6.2% of the portfolio.
Compared with Q3 2019, the fund opened 6 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 96.0% · $2.6B
- ADR · 3.2% · $85M
- Other · 0.8% · $21M
- ETP · 0.1% · $1M
- REIT · 0.0% · $730,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| QTWOQ2 Holdings, Inc. | NEW | +148.7K | 148.7K | +$12M | $12M |
| ADPTAdaptive Biotechnologies Corpo | NEW | +322.7K | 322.7K | +$10M | $10M |
| ROKURoku, Inc. | NEW | +37.2K | 37.2K | +$5M | $5M |
| ZMZoom Video Communications, Inc | NEW | +16.0K | 16.0K | +$1M | $1M |
| EVEREverQuote, Inc. | NEW | +23.0K | 23.0K | +$790,000 | $790,000 |
| CITCintas Corp. | NEW | +2.1K | 2.1K | +$558,000 | $558,000 |
| SG7Sage Therapeutics, Inc. | ADDED | +143.3K | 236.6K | +$4M | $17M |
| RNGRingCentral, Inc. | ADDED | +278.6K | 490.4K | +$56M | $83M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $3.5B | 182 | Apr 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $4.5B | 179 | Jan 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $5.1B | 178 | Oct 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $5.1B | 177 | Jul 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $4.1B | 173 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $4.9B | 175 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $4.8B | 175 | Nov 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $4.7B | 177 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $4.7B | 180 | May 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $4.3B | 172 | Feb 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $3.9B | 177 | Nov 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $4.2B | 177 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $3.7B | 178 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $3.0B | 176 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $3.5B | 178 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $2.2B | 117 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $3.7B | 119 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $4.8B | 126 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $5.3B | 134 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $5.6B | 137 | Aug 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $5.3B | 136 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $5.7B | 118 | Feb 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $5.0B | 118 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $4.2B | 119 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $2.7B | 112 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.7B | 117 | Feb 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.6B | 111 | Nov 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $3.1B | 114 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.8B | 112 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.3B | 110 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- Virtus Fund Advisers, LLC028-11308
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.